归肺经中药提取物对人肺炎支原体的抑菌试验

doi:10.3969/j.issn.1674-3865.2018.04.002

Abstract

Abstract: Objective:To observe the effect of the water extract or ethanol extract of Houttuynia (H. cordata), pberetima and Cortex Mori, whether in compound, or used alone, or used by combining either two of them, in inhibiting Mycoplasma pneumoniae in vitro.Methods:Mycoplasma pneumoniae was cultured and the drug sensitivity test was performed. MIC method was used to determine the in vitro inhibitory effect of each group of combination on Mycoplasma pneumoniae.Results:All groups had inhibitory effect on Mycoplasma pneumoniae. Among them, the MIC value in the ethanol extract of compound group, which was significantly lower than that in the water extract and the ethanol extract of Houttuynia cordata，the water extract and the ethanol extract of Cortex Mori, the water extract and the ethanol extract of the combination group of pberetima and Cortex Mori,and the water extract and the ethanol extract of the combination group of Cortex Mori and Houttuynia cordata,the difference being statistically significant（P<0.01）.Conclusion:The Chinese medicine extract has bacteriostatic effect, and if used in combination, the effect will be enhanced.

Key words: Mycoplasma pneumoniae, Houttuynia cordata, Pberetima, Cortex Mori, Bacteriostatic

CEN Kaiying, WANG Haiying. Bacteriostatic effect of Gui-Fei-Jing Chinese medicine extract on Mycoplasma pneumoniae[J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2018, 10(4): 280-282.

[1]	Sen KONG, Liang ZHANG, Nan LIAO, Guang TU. Application research on risk factor analysis of severe Mycoplasma pneumoniae pneumonia in children based on random forest model [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 71-76.
[2]	Linlin DU, Jun LI, Cancan XU. Correlation of high‐resolution CT features and serum inflammatory levels with induced-sputum pathogen load in children with Mycoplasma pneumoniae pneumonia during acute phase [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2026, 18(1): 82-87.
[3]	Jiayu LI, Yuan SUN, Xin FENG, Ke CHANG. Experience of Professor Chang Ke in treating damp-heat syndrome of mycoplasma pneumoniae pneumonia in children with the method of dredging obstruction and resolving turbidity(Xuanbi Huazhuo) [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(5): 442-446.
[4]	SHEN Hongyan, ZHANG Xiuying, TAN Chunying, SHANG Tao, MENG Bin, MU Jingwen, TIAN Zhifan, E Mingxin, WANG Xuefeng. A multi center clinical study on the adjuvant treatment with Fuxiong powder for children with Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(2): 93-98.
[5]	WU Pan, HUANG Tingyue, ZHANG Zhanling, WANG Xuefeng. Meta analysis and GRADE evaluation of Xiaoer Feire Kechuan oral liquid in the treatment of Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2025, 17(2): 98-108.
[6]	KONG Xinyue, WANG Xuefeng, WANG Yulin. Analysis of the distribution of traditional Chinese medicine constitution and susceptible risk factors of severe Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2024, 16(6): 495-499.
[7]	LUO Zihao, GENG Gang, WANG Yanhong, LI Shaojun. Risk factors for Mycoplasma pneumoniae pneumonia with plastic bronchitis in children:a systematic review and Meta-analysis [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2024, 16(6): 500-508.
[8]	QU Shengyue, MU Jingwen, YANG Jianshu, ZHAO Hangyu, ZHANG Xiuying, WANG Xuefeng. Clinical efficacy observation of Xiaoer Kechuanling oral solution (concentrated) in the treatment of Mycoplasma pneumoniae pneumonia in children [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2024, 16(5): 431-435.
[9]	MA Yunhong, WANG Shuangyi, LUO Fei, ZHANG Yuan, CUI Zhengjiu, DIAO Juanjuan. Clinical study on coagulation function of children with Mycoplasma pneumoniae lobar pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2024, 16(3): 234-238.
[10]	WANG Xuefeng, SHANG Yunxiao, CHENG Huanji, WANG Youpeng, FENG Xiaochun, WU Zhenqi, SUN Liping, YANG Nan, QU Shuqiang, WANG Hai, ZHANG Xiuying, CHENG Qi. Prevention and treatment scheme of integrated traditional Chinese and western medicine for respiratory tract infection of Mycoplasma pneumoniae in children in Northeast China [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2023, 15(6): 461-466.
[11]	ZHANG Songlin, GUO Yanjun, FENG Risheng. Significances of detection of T cell subsets，IgE and RANTES in infants with refractory Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2023, 15(3): 229-232.
[12]	SU Yonghong, SUN Xueli, YANG Lili, YAN Wenjuan, WU Chunlian. Risk factors of myocardial damage in children with Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(4): 323-325.
[13]	LIAN Chaoyu, XU Guangming, YAN Yanjie, YANG Junge. Relationship between disease severity and levels of vitamin D,C-reactive protein and D-dimer in children with Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(3): 225-228.
[14]	YAN Qiuli, HAO Chuangli. Clinical study of bronchoscopy intervention at different time points for children with refractory Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(2): 138-141.
[15]	YUAN Xiaoxu, JIA Chunmei. The clinical significance of D-dimer level in children with severe Mycoplasma pneumoniae pneumonia [J]. Chinese Pediatrics of Integrated Traditional and Western Medicine, 2022, 14(1): 29-32.

Bacteriostatic effect of Gui-Fei-Jing Chinese medicine extract on Mycoplasma pneumoniae

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments